Role of the Gastrografin test in adhesive small bowel obstruction in adults in Senegal
DOI:
https://doi.org/10.18203/2349-2902.isj20261163Keywords:
Senegal, Water-soluble contrast agent, Nonoperative management, Small bowel obstruction, Gastrografin testAbstract
Background: Adhesive small bowel obstruction (ASBO) is a common surgical emergency, particularly in low-resource settings where delayed presentation and limited diagnostic resources complicate management. The Gastrografin test may help predict successful conservative treatment. This study evaluated its role in guiding the management of ASBO in adults in Senegal.
Methods: A prospective descriptive study with an analytical component was conducted in the Department of General Surgery at Aristide Le Dantec University Hospital in Dakar, Senegal, from December 2015 to December 2021. Adult patients diagnosed with ASBO without clinical or radiological signs of severity were included. All patients underwent a standardized Gastrografin test. The test was considered positive when contrast medium reached the right colon within 24 hours. Clinical outcomes, need for surgical intervention, length of hospital stay, and the diagnostic performance of the test were analyzed.
Results: Twenty-seven patients were included (16 men and 11 women), with a mean age of 39.7±17.3 years. Fourteen patients (51.9%) had a positive Gastrografin test, among whom 13 (48.1%) experienced resolution of obstruction without surgery. Fourteen patients (51.9%) required surgery due to a negative test (n=13) or recurrence after initial improvement (n=1). The specificity of the Gastrografin test was 92.9%. Patients with a positive test had a shorter mean hospital stay (4.76 vs. 5.33 days). No mortality occurred.
Conclusions: The Gastrografin test is a simple and accessible tool for the management of ASBO. It helps identify patients suitable for conservative treatment while guiding timely surgical intervention.
References
Biondo S, Pares D, Mora L, Martí Ragué J, Kreisler E, Jaurrieta E. Randomized clinical study of Gastrografin administration in patients with adhesive small bowel obstruction. Br J Surg. 2003;90(5):542-6.
Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999;353(9163):1476-80.
Di Saverio S, Catena F, Ansaloni L, Gregorio Tugnoli, George C Velmahos, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction. World J Emerg Surg. 2013;8:42.
Cohen RB, Olafson SN, Krupp J, Parsikia A, Kaplan MJ, Moran B, et al. Timing of Gastrografin administration in the management of adhesive small bowel obstruction (ASBO): Does it matter?. Surgery. 2021;170(2):596-602.
Nishie H, Shimura T, Katano T, Iwai T, Itoh K, Ebi M, et al. Long-term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction. J Gastroenterol Hepatol. 2022;37(1):111-6.
Scotté M, Mauvais F, Bubenheim M, Cossé C, Suaud L, Savoye-Collet C, et al. Use of water-soluble contrast medium (gastrografin) does not decrease the need for operative intervention nor the duration of hospital stay in uncomplicated acute adhesive small bowel obstruction?. A multicenter, randomized, clinical trial (Adhesive Small Bowel Obstruction Study) and systematic review. Surgery. 2017;161(5):1315-25.
Assalia A, Schein M, Kopelman D, Hirshberg A, Hashmonai M. Therapeutic effect of oral Gastrografin in adhesive small bowel obstruction: a prospective randomized trial. Surgery. 1994;115(4):433-7.
Choi HK, Chu KW, Law WL. Therapeutic value of Gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial. ANZ J Surg. 2002;236(1):1-6.
Feigin E, Seror D, Szold A, Carmon M, Allweis TM, Nissan A, et al. Water-soluble contrast material has no therapeutic effect on postoperative small bowel obstruction: a prospective randomized controlled clinical trial. Am J Surg. 1996;171(2):227-9.
Abbas S, Bissett IP, Parry BR. Oral water soluble contrast for the management of adhesive small bowel obstruction. Cochrane Database Syst Rev. 2007;3.
Kostenbauer JK, Truskett PG. Current management of adhesive small bowel obstruction. ANZ J Surg. 2018;88(11):1117-22.
Goussous N, Eiken PW, Bannon MP, Zielenski MD. Enhancement of a small bowel obstruction model using the gastrografin® challenge test. J Gastrointest Surg. 2013;17:110-7.
Fevang BT, Jensen D, Svanes K, Viste A. Early operation or conservative management of patients with small bowel obstruction?. Eur J Surg. 2002;168:475-81.
Nauta RJ. Advanced abdominal imaging is not required to exclude strangulation if complete small bowel obstructions undergo prompt laparotomy. J Am Coll Surg. 2005;200:904-11.